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An earlier randomised-controlled trial demonstrated the positive effects of cognitive behaviour therapy (CBT), especially designed for
fatigued cancer survivors in reducing fatigue, functional impairments and psychological distress. In the current prospective study, we
were able to examine the long-term effect of CBT in patients who completed the therapy. Predictors of fatigue severity at follow-up
were exploratory investigated. Sixty-eight patients who completed CBT were assessed at pretreatment, post-treatment and at
follow-up (mean follow-up 1.9 years (s.d. 1.0), range: 1–4 years). To analyse possible predictors of treatment outcome a linear
regression (enter) was carried out. Improvements on fatigue severity, functional impairment and psychological distress after CBT
appeared to remain stable during a follow-up period. Patients who were not fatigued anymore at follow-up were not different from a
reference group of non-fatigued cancer survivors. The explorative regression analysis showed that fatigue severity, psychological
distress and somatic attributions at pretreatment contributed to persistent fatigue severity at follow-up. Cognitive behaviour therapy,
especially designed for post-cancer fatigue, is successful in reducing fatigue and functional impairment in cancer survivors. Moreover,
these positive effects were maintained at about 2 years after finishing CBT.
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Fatigue is a common and distressing side effect of cancer treatment
(Servaes et al, 2002b; Prue et al, 2006). Unfortunately, fatigue
persists in patients for even years after completion of curative
treatment. At least a quarter of the cancer survivors suffer from
post-cancer fatigue, with profound effects on quality of life
(Servaes et al, 2002b, in press; Hjermstad et al, 2005; Sugawara
et al, 2005; Bower et al, 2006; Prue et al, 2006).
Although research on post-cancer fatigue has increased in the
last decennia, there are only a few randomised-controlled trials
(RCTs) investigating the management of post-cancer fatigue. Until
now, six RCTs have investigated the effect of an intervention on
fatigue, measured as a primary or secondary outcome. Two were
pilot studies and found no effect on fatigue (Basen-Engquist et al,
2006; Culos-Reed et al, 2006). No effect was found investigating a
lifestyle physical activity intervention (Basen-Engquist et al, 2006)
and the second study found no effect of yoga (Culos-Reed et al,
2006). Two studies investigated the effect of exercise in cancer
survivors. Both studies used fatigue as a secondary outcome and
showed beneficial effects (Courneya et al, 2003; Pinto et al, 2005).
The fifth study found that acupuncture was a more effective
method to improve fatigue compared with acupressure or sham
acupressure (Molassiotis et al, in press). None of these RCTs
includes follow-up assessments. In the last RCT cognitive
behaviour therapy (CBT), especially designed for post-cancer
fatigue, appeared to be highly effective (Gielissen et al, 2006). The
rationale of this intervention was based on the model of
precipitating and perpetuating factors. Fatigue seems to be elicited
during the treatment phase, but later on there is no clear
relationship between persistent fatigue and initial disease and
cancer treatment variables (Servaes et al, 2002b; Hjermstad et al,
2005; Ng et al, 2005; Prue et al, 2006; Young and White, 2006). The
assumption is that the cancer itself and/or the cancer treatment
may have triggered fatigue (precipitating factors), but other factors
are responsible for persistence of fatigue complaints (perpetuating
factors). Cognitive behaviour therapy for post-cancer fatigue is
focused on these perpetuating factors. The RCT consisted of two
conditions, the intervention condition (6 months of CBT) and
waiting list condition (6 months). Patients in the intervention
condition reported a clinically relevant decrease compared to
patients in the waiting list condition in fatigue severity, functional
impairment and psychological distress. Patients in the waiting list
condition were informed beforehand that, if desired, they could
start therapy directly after the waiting period of 6 months.
In this current study, the long-term effect of CBT will be
investigated in patients who were involved in this former study
and received CBT, including patients in the intervention condition
and patients who had been treated after the 6-month waiting list.
Furthermore, we will exploratory investigate predictors of fatigue
severity at follow-up.
METHODS
Sample
Between December 2001 and September 2004, six departments of
the Radboud University Nijmegen Medical Centre participated in
the recruitment of patients for this study. Cancer survivors who
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sexperienced severe fatigue (score of 35 or higher on the Checklist
Individual Strength, fatigue subscale) were recruited from the
outpatient clinics of medical oncology, urology, surgery, ortho-
paedic, haematology and gynaecology. During follow-up visits in
the hospital fatigued survivors were screened by their physician on
clinically relevant systematic diseases (eg, malnutrition, haemo-
globin level, presence of hypothyroidism and other physical
comorbidities). If a physician was certain that the fatigue had no
somatic cause, the patient was invited to participate. Patients
completed curative treatment for cancer at least 1 year ago and had
a minimal age at disease onset of 18 years. At time of participation
patients had no evidence of disease recurrence and patients were
not older than 65 years. Patients with current psychological or
psychiatric treatment were excluded. The ethics committee of the
hospital approved the study.
Intervention
Cognitive behaviour therapy was focused on six perpetuating
factors of post-cancer fatigue, which were based on existing
literature and experience in clinical practice. They involve (1)
insufficient coping with the experience of cancer, (2) fear of
disease recurrence (Servaes et al, 2003; Young and White, 2006),
(3) dysfunctional cognitions concerning fatigue (Broeckel et al,
1998; Servaes et al, 2002c), (4) dysregulation of sleep (Servaes et al,
2002b; Prue et al, 2006), (5) dysregulation of activity (Servaes
et al,2 0 0 2 a ;P r u eet al, 2006; Young and White, 2006) and (6) low
social support and negative social interactions (Servaes et al,2 0 0 2 c ) .
Each perpetuating factor became a module in the therapy
protocol. Because of the existence of large differences within the
group of fatigued cancer survivors (Servaes et al, 2002a), therapy
was adapted to each individual. To determine which modules were
necessary, each perpetuating factor was measured with specific
questionnaires. If a patient scored problematic on one of these
questionnaire, the accessory module became part of the treatment,
resulting in an individualised treatment protocol per patient. It is
important to realise that the therapy only varied in number of
modules, but within each module the therapy is standardised.
The number of sessions was determined by the number of used
modules and by reaching the goal of the therapy.
Three therapists with previous CBT experience in patients with
chronic fatigue treated patients who started directly with CBT as
well as patients who started CBT after the waiting list period. For a
more detailed description of the intervention see Gielissen et al
(2006) (see Appendix A).
Assessment
Patients were asked to complete questionnaires at the Expert
Centre Chronic Fatigue of the Radboud University Nijmegen
Medical Centre, pretreatment and post-treatment. Additionally, a
package of questionnaires was sent by mail to all patients 6 months
after the last patient finished CBT.
Outcome measures Fatigue severity was measured by the fatigue
severity subscale of the checklist individual strength (CIS)
(Vercoulen et al, 1994; Beurskens et al, 2000; Dittner et al, 2004).
The questionnaire has been used in cancer survivors (Servaes et al,
2002a,c, 2003, in press; Gielissen et al, 2006), showed good
reliability, discriminative validity and sensitivity to change
(Beurskens et al, 2000; Prins et al, 2001; Stulemeijer et al, 2005;
Gielissen et al, 2006).
Functional impairment was measured by the sickness impact
profile-8 (SIP-8). This widely used measure has good reliability
and content validity (Bergner et al, 1981; Jacobs et al, 1990).
Psychological distress was measured by the symptom check list
90, which has good reliability and discriminating validity (Arindell
and Ettema, 1986; Derogatis, 1994).
Perpetuating factors Coping with the experience of cancer was
measured with the Dutch version of the Impact of Event Scale,
which measures the extent to which a subject is currently occupied
with the coping process after a major event (in this study the
diagnose and treatment for cancer) (Brom and Kleber, 1985;
Creamer et al, 2003; van der Ploeg et al, 2004).
Fear of disease recurrence was measured by two items of the
Cancer Acceptance Scale (CAS) (Servaes et al, 2003).
Cognitions related to fatigue. Self-efficacy was measured with the
Self-Efficacy Scale (Vercoulen et al, 1998; Prins et al, 2001; Servaes
et al, 2002c, 2003) and somatic related attributions with regard to
fatigue complaints were measured with the Causal Attribution List
(CAL) (Servaes et al, 2002c).
Sleep disturbances was measured with the sleep/rest subscale of
the SIP-8, and the insomnia subscale of the Quality of Life
Questionnaire-C30 (QLQ-C30) (Aaronson et al, 1993).
Physical activity was measured with the physical functioning
and role functioning subscale of the QLQ-C30. Furthermore,
physical activity was measured with the subscales home manage-
ment, work and recreation and pastimes from the SIP.
Social functioning was measured with the van Sonderen Social
Support Inventory (SSL) (van Sonderen, 1993).
Statistical analysis
Data analyses were performed using SPSS (version 12.1).
Independent samples t-test and w
2-squared tests were performed
testing differences between the intervention condition and the
waiting list condition.
In the current study, the data collected at the end of the 6-month
waiting period were used as pretreatment measurements. Com-
parison of the results of the pretreatment, post-treatment and
follow-up assessments were carried out by GLM repeated measures
analysis. Furthermore, GLM multivariate analysis was performed
testing the differences between different follow-up periods and
with a reference group. In a previous study of our research group
93 non-fatigued breast cancer patients were identified and used in
this study as reference group (CISo35; mean age, 46.4 years;
s.d.¼6.3; Servaes et al, 2002c).
Mann–Whitney U-tests were used testing the differences
between patient who did not accept CBT after the 6-month waiting
list period and patients who completed CBT.
McNemar tests were used to analyse the differences between
the proportions of patients who did not meet the criteria for
severe fatigue (CIS-fatigueo35) anymore at post-treatment and
follow-up.
To analyse possible predictors of treatment effects a linear
regression (enter) was carried out, with fatigue severity at the last
follow-up assessment as dependent variable. Pearson correlations
between fatigue severity at follow-up and the six perpetuating
factors were used as preparatory analyses to examine the
contribution of these factors to fatigue severity. Those measures
that correlated significant with the fatigue severity at follow-up
were used as independent variables in the logistic regression
analyses. Correlations between the six perpetuating factors were
tested on multicollinearity (ro0.9).
RESULTS
Sample
Figure 1 shows the trial profile. The controlled data are described
in Gielissen et al (2006). In this current study, we used the pooled
data of both conditions. In the intervention condition, 38 patients
completed CBT of whom 36 had a follow-up assessment. Forty-
four patients completed the 6-month waiting list period and were
offered CBT. Thirty-two patients accepted and completed the
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stherapy and the follow-up assessment. There were no significant
differences between patients in the intervention condition and
waiting list condition on demographic and medical characteristics
(Table 1). In addition, no significant differences were found on the
outcome variables at pretreatment (fatigue severity P¼0.052;
functional impairment P¼0.210; psychological distress P¼0.300)
Entered study
(n = 50) 
Entered study
(n = 48) 
Intervention condition 
(n = 56) 
Excluded from trial (n=6) 
Disease recurrence  (n=3) 
Medical explanation for fatigue  (n=1)
Waiting list condition 
(n = 56) 
Excluded from trial (n=8)  
Disease recurrence (n=7)
Failed to fill out questionnaires (n=1) Failed to fill out questionnaires (n=2)
Randomisation 
(n = 112) 
Eligible to enter trial 
n=145
Refused participation   (n=33)
Takes to much time   (n=9) 
Did not feel like taking part   (n=5)
Study site too far from home   (n=6)
Too tired to participate   (n=4) 
Wanted to move on with their lives   (n=3) 
Did not believe CBT would help them   (n=3) 
Did not want to risk allocation to waiting list condition  (n=1) 
Reason unknown   (n=2) 
Complete 2 assessment
CBT was offered
(n = 44)
Withdrew from study   (n=4) 
Study takes too much time  (n=2) 
Refused further participation after 
Randomisation to the waiting list 
Condition  (n=2)  
Not starting therapy (n=5) 
Therapy takes too much time  (n=2) 
Priority to other health issues  (n=2) 
Reason unknown  (n=1) 
Drop out   (n=7)  
Therapy takes too much time  (n=3)
Did not want to change their lives (n=2) 
Too emotional  (n=1) 
Moved to Spain (n=1) 
Accepted CBT and  
completed follow-up 
assessment
(n = 32) 
Did not accept CBT  (n=12)
Therapy takes too much time  (n=6) 
Did not want to change their lives (n=2)
Not fatigued anymore  (n=2) 
Traveling to expert centre for therapy 
Too expensive (n=2)
Complete follow-up 
assessment
(n = 36)
Pooled follow-up 
assessment
(n = 68) 
No follow-up assessment  (n=2) 
Assessment and traveling to the 
Expert centre takes too much time  
(n=2)
Completers CBT    
(n = 38) 
Figure 1 Trial profile.
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sand post-treatment (fatigue severity P¼0.582; functional impair-
ment 0.118; psychological distress P¼0.346). Furthermore, the
number of CBT sessions in both conditions were equal (12.5 (4.7)
vs 12.4 (4.6), P¼0.853). Because no differences were found, the
data of both conditions were pooled (Table 1).
Furthermore, we compared patients who did not accept CBT
after the 6-month waiting list period (n¼12) with patients who
completed CBT (n¼68). There were no differences in the
pretreatment assessment on fatigue severity (P¼0.205), functional
impairment (P¼0.925) and psychological distress (P¼0.671).
Seven of the 12 patients who did not accept CBT after the waiting
list period, completed the follow-up assessment.
Long-term effect
The mean length of time between completion of therapy and
follow-up assessment was 1.9 years (s.d.¼1.0) with a range of 6
months to 4 years. The median was 2.0 years. The time interval
between completion of therapy and follow-up assessment varied
because patients entered the study at various times and started
treatment at different moments.
Information about the outcome variables at the three assess-
ments are listed in Table 2. Scores of fatigue severity, functional
impairment and psychological distress significantly decreased at
post-treatment and follow-up assessment compared with the
pretreatment assessment. Additionally, the means on all outcome
measures remained stable between post-treatment and follow-up.
Compared with the reference group, patients in this study were
significantly more fatigued at follow-up assessment, but had the
same level of functional impairment and psychological distress.
The follow-up period of patients who did not accept CBT (n¼7)
was comparable with the follow-up period of patients who
completed CBT (1.5 years (s.d.¼0.8), P¼0.145). Patients who
did not accept CBT were significantly more fatigued, had more
functional impairments and higher psychological distress at
follow-up compared to patients who accepted CBT (Table 2).
Eighty-one percent (n¼55) of the patients did not meet the
criteria of severe fatigue at post-treatment (CIS-fatigueX35). At
follow-up this percentage of non-fatigued patients was 71%
(n¼48, P¼0.118). Compared with the non-fatigued reference
group (Table 2), the patients who were not fatigued after CBT
(n¼48) had the same level of fatigue (19.9; s.d.¼8.4, P¼0.842),
the same level of functional impairment (271.0; s.d.¼292.7,
P¼0.476) and a significantly lower level of psychological distress
(106.3; s.d.¼14.4, P¼0.042).
Short- vs long-term follow-up
As there is a considerable range in the duration of the follow-up,
we investigated whether the treatment outcome differed between
patients with a shorter and a longer follow-up period. Patients
were divided into four groups: patients who completed CBT
between 6 months and 1 year ago (n¼15), between 1 and 2 years
ago (n¼21), between 2 and 3 years ago (n¼20), and between 3
and 4 years ago (n¼12). Post hoc analyses showed no significant
differences on change scores (pretreatment scores  /  follow-up
scores) between the four-follow-up period on fatigue severity,
functional impairment and psychological distress (Table 3).
Furthermore, correlations between time since CBT and fatigue
severity (r¼ 0.067, P¼0.585), functional impairment (r¼216,
P¼0.077) and psychological distress (r¼141, P¼0.251) were low
and nonsignificant.
Predictors
Results of the preparatory analyses indicated that fatigue at follow-
up was significantly correlated with fatigue severity (CIS-fatigue,
r¼0.354, P¼0.003), psychological distress (SCL90-total, r¼0.398,
P¼0.001), somatic related attributions (CAL, r¼0.293, P¼0.015)
and insufficiency in social interactions (SSL-D, r¼0.316,
P¼0.009) at pretreatment. These variables were used as indepen-
dent variables in the linear regression analysis. Table 4 summarise
the regression analysis. Somatic attributions contributed almost
significantly (P¼0.050) to fatigue severity at follow-up. Further-
more, a trend was seen for pretreatment fatigue severity
(P¼0.064) and psychological distress (P¼0.074).
DISCUSSION
The results of the present study indicate that the positive results of
CBT especially designed for fatigued cancer survivors were
maintained at follow-up. Fatigue severity, functional impairment
and psychological distress remained stable in patients who
Table 1 Characteristics of study participants
CBT
(n¼36)
Waiting list
(n¼32)
Pooled group
(n¼68)
Age (years) 43.8 (10.3) 43.9 (10.3) 43.8 (10.2)
M/F (n) 19/17 16/16 35/33
Cancer diagnosis % (n)
Mamma carcinoma 36% (13) 25% (8) 31% (21)
Testicular cancer 33% (12) 25% (8) 29% (20)
Haematological cancer 17% (6) 16% (5) 16% (11)
Other solid tumours 14% (5) 34% (11) 24% (16)
Treatment type % (n)
a
Surgery 75% (27) 81% (26) 78% (53)
Chemotherapy 70% (24) 84% (27) 75% (51)
Radiotherapy 53% (19) 44% (14) 49% (33)
Duration of cancer treatment
(months)
6.6 (7.1) 7.3 (6.3) 6.9 (6.7)
Time since cancer treatment
(years)
5.2 (4.0) 5.1 (3.6) 5.1 (3.8)
CBT¼cognitive behaviour therapy. Values are means (s.d.) unless stated otherwise.
aPercentages do not add up to 100% because more options are possible.
Table 2 Means and s.d. of CBT completers at pretreatment, post-treatment and follow-up, a reference group of non-fatigued cancer survivors and
non-accepters of CBT at follow-up assessment
N¼68 A pretreatment B post-treatment C follow-up
D reference
values (n¼98)
Non-accepters CBT
at follow-up (n¼7)
Fatigue severity 45.3 (7.7)
a,b,c 24.3 (10.9)
c,d 26.9 (13.1)
c,d 19.6 (8.4)
a,b,d 40.3 (14.8)
e
Functional impairment 937.1 (530.4)
a,b,c 415.1 (438.6)
d 429.8 (483.2)
d 309.5 (333.4)
d 842.9 (302.2)
e
Psychological well-being 138.5 (35.6)
a,b,c 113.6 (25.5)
d 119.3 (37.1)
d 113.2 (20.3)
d 138.6 (39.8)
CBT¼cognitive behaviour therapy.
aSignificantly different from post-treatment assessment (Po0.05).
bSignificantly different from the follow-up assessment (Po0.05).
cSignificantly different from the reference group (Po0.05).
dSignificantly different from pretreatment assessment (Po0.05).
eSignificantly different from follow-up assessment of
CBT-completers.
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scompleted CBT after almost a mean follow-up period of 2 years.
Furthermore, we could not find any difference between patients
with a short- and a long-term follow-up. Therefore, even after 4
years the positive effect of CBT remained.
Patients who were allocated to the 6-month waiting list were
offered CBT directly after the second assessment. Therefore, the
long-term effect was investigated with an uncontrolled design.
Nevertheless, patients who were recovered at follow-up were
comparable with a reference group of non-fatigued cancer
survivors. Additionally, we investigated a small group of patients
who did not accept CBT after the waiting list period. These patients
did not improve over time on fatigue severity, functional
impairment and psychological distress. Because of the small
sample size, we should be careful in interpreting these results.
Patients could have improved regardless of the followed treatment.
It would increase the impact of our findings if future studies could
prove the long-term superiority of CBT over natural course in
fatigued cancer survivors. Another reason why it is difficult to
draw firm conclusions is that follow-up data were not available of
all patients who participated in the previous RCT.
The explorative regression analysis showed a trend that patients
with more fatigue, higher psychological distress and stronger
somatic attributions at pretreatment were more fatigued at the
follow-up assessment. Fatigued cancer survivors have the tendency
to attribute their fatigue complaints to the cancer itself and/or
cancer treatment (Servaes et al, 2002c). However, research on post-
cancer fatigue fails to show such relationship, which makes this a
false attribution (Servaes et al, 2002b; Hjermstad et al, 2005; Ng
et al, 2005; Prue et al, 2006; Young and White, 2006). In the current
model of post-cancer fatigue, we assume that fatigue originates in
the diagnostic and treatment stage; however, there is no clear
relationship between fatigue long after curative treatment and the
initial disease and cancer treatment characteristics. Because
somatic attributions still proved to contribute to fatigue at
follow-up in this study, it seems that this aspect has received not
enough attention during the CBT. If a patients continues to think
that the cancer itself and/or cancer treatment is responsible for
the experienced fatigue, the chance on recovery is lowered. It is
possible that (further) education on post-cancer fatigue for
professionals working in cancer care can increase the chance of
improvement with CBT. Somatic attributions in fatigued cancer
survivors can be reinforced by inaccurate information delivery
about the cause of post-cancer fatigue. Therefore, education
should be aimed particularly on the model of precipitating and
perpetuating factors.
Furthermore, indications were found that patients with high
psychological distress had a worse treatment outcome. Extreme
high scores on the SCL90 total score (4200) are indicative for
psychiatric comorbidity (Arindell and Ettema, 1986). Five patients
in our sample met this criterion. All five patients remained
fatigued after CBT. When deleting these cases, the trend of
psychological distress as contributor to fatigue at follow-up
disappeared in the regression analysis (P¼0.776). Therefore,
fatigued cancer survivors with high scores on psychological
distress (probably indicative of psychiatric comorbidity) proved
to have hardly any chance to improve with CBT for post-cancer
fatigue. However, results from the regression analyses should be
regarded as exploratory and interpreted with caution.
Most studies on post-cancer fatigue do not find an association
between fatigue and cancer type (Servaes et al, 2002b; Prue et al,
2006; Gielissen et al, 2007). In the current study, we did not find a
significant difference in fatigue severity at baseline between the
different types of cancer (P¼0.821). There was also no difference
in effect of CBT on fatigue severity (P¼0.983). However, our study
was limited to patients with rather frequently diagnosed tumours.
Therefore, replication is necessary in survivors with other cancer
types.
The long-term follow-up results of our study shows that the
positive effects of CBT especially designed for post-cancer fatigue
are maintained even years after treatment. Until now, no other
interventions have been published with comparable good results
on post-cancer fatigue on the long term.
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Appendix A
Table A1 Patients were asked to complete questionnaires at the Expert Centre Chronic Fatigue of the Radboud University Nijmegen Medical Centre,
pretreatment and post-treatment.
Questionnaires Response format Example questions
Fatigue severity Checklist Individual strength – subscale
Fatigue Severity (8 items)
Seven-point Likert scale I feel tired
Range 8–56 I am rested
A score of 35 indicates severe fatigue Physically I feel exhausted
Functional impairment SIP-8
Home management (10 items)
Mobility (10 items)
Alertness behaviour (10 items)
Sleep/rest (7 items)
Ambulation (12 items)
Social interactions (20 items)
Work (8 items)
Recreation and pastimes (8 items)
Patients can mark a box behind each statement.
A total score is calculated by addition the
weights of items
Range 0–5799
I am not doing any of the house cleaning that I
would usually do (hm)
I am not going out to visit people at all (si)
I walk shorter distances or stop to rest often
(amb)
I react slowly to thing that are said (alert)
I have difficulty doing activities involving
concentration and thinking (alert)
Psychological distress Symptom Check List 90 (90 items)
Anxiety (10 items)
Agoraphobia (7 items)
5 point Likert scale
Range 90–450
During the past 7 days about how much were
you distressed or bothered by:
Feeling fearful (anx)
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Questionnaires Response format Example questions
Depression (16 items)
Somatisation (12 items)
Obsessive-compulsive behaviour (9 items)
Interpersonal sensitivity (18 items)
Hostility (6 items)
Sleep (3 items)
Feeling of worthlessness (depr)
Numbness or tingling in parts of your body
(som)
Feeling that people are unfriendly or dislike
you (int.sens)
Nervousness or shakiness inside (anx)
Coping with the
experience of cancer
Impact of Event Scale
Intrusion (7 items)
Avoidance (8 items)
6-point Likert Scale
Range 13–52
I had dreams about it (intr)
I tried not to think about it (avoid)
I tried not to talk about it (avoid)
Fear of disease
recurrence
Cancer Acceptance Scale 4-point Likert Scale
Range 2–8
I am worried about a tumour relapse
I am anxious about my health
Cognitions related to
fatigue
Self Efficacy Scale (7 items) 4-point Likert Scale
Range 7–28
Whatever I do, I cannot change my complaints
I think I could positively influence my fatigue
Causal Attribution List – subscale somatic
attribution (4 items)
4-point Likert Scale
Range 4–16
Do you think your complaints have to do with
the anti-cancer treatment?
Sleep disturbance SIP-8 – subscale Sleep/Rest 4-point Likert Scale I sleep more during the day
EORTC QLQ-C30 – subscale Insomnia
(1 item)
Have you had trouble sleeping?
Physical activity EORTC QLQ-C30 – subscale physical
functioning (5 items)
EORTC QLQ-C30 – subscale role functioning
(2 items)
SIP-8 – Home management
SIP-8 – Work
SIP-8 – Recreation and Pastimes
Yes/No; range 5–10
4-point Likert Scale; range 2–8
Patients can mark a box behind each statement.
Do you have trouble waling a long walk?
Has your physical condition interfered with
your family life?
I am not doing any of the clothes washing
At work, I make more mistakes than usually
I am doing fewer community activities
Social functioning Van Sonderen Social Support Inventory
SSL-I: amount of social support (34 items)
SSL-D: insufficiency of supporting
interactions (34 items)
SSL-N: amount of negative interactions
(7 items)
4-point Likert Scale
Range 34–136
Range 34–135
Range 7–28
Do you experience friendliness and sympathy in
your contacts with other people?
Do you talk problems over with other people?
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